Showing results (1271-1280 of 1,341) with videos related to
Sort By:
Pageof 135
Scientific Reports|August 8, 2025
Exposotypes in psychotic disordersWalid Yassin, Bryan Kromenacker, James B Green, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 15, 2024
Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trialKaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, et al.JAMA Internal Medicine|March 17, 2025
Nudging Clinicians to Promote Serious Illness Communication for Critically Ill Patients: A Pragmatic Cluster Randomized TrialKatherine R Courtright, Jaspal Singh, Erich M Dress, et al.Journal of Diabetes and Its Complications|January 20, 2023
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, Javed Butler, George L Bakris, et al.The New England Journal of Medicine|December 4, 1980
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgeryM D Walker, S B Green, D P Byar, et al.Cell Metabolism|August 8, 2019
Medicine in the Fourth DimensionChristopher R Cederroth, Urs Albrecht, Joseph Bass, et al.American Journal of Hypertension|February 11, 2015
Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three InterventionsMark A Espeland, Jeffery Probstfield, Donald Hire, et al.Journal of the American Heart Association|May 19, 2021
Inequities in Hypertension Control in the United States Exposed and Exacerbated by COVID-19 and the Role of Home Blood Pressure and Virtual Health Care During and After the COVID-19 PandemicAdam P Bress, Jordana B Cohen, David Edmund Anstey, et al.JCI Insight|July 2, 2026
A Validated, Modifiable Proteomic Score from the EXSCEL Trial Predicts Cardiovascular Events in DiabetesKristin M Corey, Maggie Nguyen, Michael Y Mi, et al.Diabetes Care|October 8, 2017
Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS TrialAbhinav Sharma, Jennifer B Green, Allison Dunning, et al.Pageof 135